NPPB and atrial fibrillation: The NT-proBNP cutoff for inclusion in the BIOSTAT-CHF index cohort could have potentially led to higher inclusion rates of SR patients with more severe HF as compared with those with AF, and as compared with patients included in the validation cohort.